Migraine Headache Treatment and Management Nursing

How To Take A quiz?

Fill out all required information.
Carefully read the question.
Then choose the answer and click on it.
Correct/Incorrect response will be displayed.
Use "Next" button to go to the next question.
Score will be shown at the conclusion of the quiz.
Received Passing score - Great ! close the browser window
Received Failed score - Retake quiz until you pass

Ready? Let's click on "Start Quiz" button and get started !

Please enter Full Legal Name (First and Last Name) to be printed on the certificate.

1 / 20

Migraine Headache Treatment and Management

Question 1:

Which of the following is not a frequent concomitant symptom that can accompany a migraine attack?

A) Nausea and vomiting

B) Sensitivity to light and sound

C) Aura

D) Increased heart rate

2 / 20

Migraine Headache Treatment and Management

Question 2:

Menstrual-associated migraines occur cyclically and affect up to what percentage of women?

A) 50

B) 10

C) 25

D) 45

3 / 20

Migraine Headache Treatment and Management

Question 3:

At this point in research, it is thought that migraines occur due to stimulation in:

A) The peripheral nervous system

B) The central nervous system

C) Both the peripheral and central nervous systems

D) The autonomic nervous system

4 / 20

Migraine Headache Treatment and Management

Question 4:

Which of the following is NOT suspected to be a factor in migraine occurrence?

A) Recurrent headache of moderate to severe intensity

B) Numbing of extremities

C) Visual aura

D) Family history of migraine

5 / 20

Migraine Headache Treatment and Management

Question 5:

Which of the following are most characteristic of the postdrome phase of migraine?

A) Fatigue and extreme hunger

B) Light-headedness and mood alterations

C) Aura and neck discomfort

D) Photophobia and phonophobia

6 / 20

Migraine Headache Treatment and Management

Question 6:

Treatment goals of migraine management include alleviating acute pain, restoring normal functioning, preventing relapse, and minimizing side effects.

A) True

B) False

7 / 20

Migraine Headache Treatment and Management

Question 7:

According to studies, the majority of patients experiencing episodic migraines have received consultation, diagnosis, and a treatment plan that includes preventative therapies when appropriate.

A) True

B) False

8 / 20

Migraine Headache Treatment and Management

Question 8:

Which of the following is not an important component of patient understanding in migraine management?

A) Understanding of their condition and setting realistic expectations

B) Treatment approach and the importance of adhering to a prophylactic regimen

C) Medication is most useful at the migraine’s onset

D) Taking over-the-counter analgesics continuously is considered safe and does not result in any known complications

9 / 20

Migraine Headache Treatment and Management

Question 9:

Medication-overuse headaches, which within hours of discontinuation of the offending medication and are relieved with re-administration, can be precipitated by which circumstances?

A) Using prescription medication intended for acute treatment on >10 days monthly

B) Using over-the-counter medications intended for acute treatment on >15 days monthly

C) Using acute treatment medications >3 times weekly

D) All of the above

10 / 20

Migraine Headache Treatment and Management

Question 10:

Chewable tablets and orally-disintegrating acute medications contain aspartame and phenylalanine and should be avoided in individuals with what condition?

A) Phenylketonuria

B) Hypertension

C) Elevated blood sugar

D) Liver disease

11 / 20

Migraine Headache Treatment and Management

Question 11:

Which of the following is not a caution that must be considered in prescribing triptans?

A) Eletriptan is contraindicated with strong CYP 3A4 inhibitors, and the dose of almotriptan must be adjusted

B) The patient must be counseled on transient pressure in the chest as a possible side effect

C) Triptans are contraindicated in patients with coronary artery disease due to their vasoconstrictive properties

D) All of the above

12 / 20

Migraine Headache Treatment and Management

Question 12:

When compared to triptans, why are ergotamines not considered first-line agents for acute migraine management?

A) They are nonselective serotonin agonists and are therefore associated with more prolific adverse effects

B) They are potent agents and require more frequent monitoring and dose adjustments

C) They are metabolized by the liver rather than the kidneys and extensive drug interactions with other migraine medications must be taken into account

D) They are not available as nasal sprays and onset of action may be delayed

13 / 20

Migraine Headache Treatment and Management

Question 13:

Butalbital-containing products should be used as last resort treatments due largely to their associated risk of:

A) Peripheral ischemia

B) Hypersensitivity reactions

C) Dependency

D) Paresthesia

14 / 20

Migraine Headache Treatment and Management

Question 14:

An important educational counseling point in encouraging adherence, preventative treatment can take up to how long after initiation for full effect?

A) Six to eight weeks

B) Two weeks

C) Two months

D) Six months

15 / 20

Migraine Headache Treatment and Management

Question 15:

Which of the following is not a parameter for measuring success of newly-started preventative migraine therapy?

A) A decrease in the duration of migraine episodes

B) A 50% reduction in the number of headaches

C) An improvement in response to acute therapy

D) Reducing prophylactic therapy use to only days that an individual experiences an attack

16 / 20

Migraine Headache Treatment and Management

Question 16:

Female sex, overuse of acute medications, and presence of comorbidities such as depression, anxiety, and obesity, are risk facotrs for transformation of episodic to chronic migraines.

A) True

B) False

17 / 20

Migraine Headache Treatment and Management

Question 17:

Which of the following agents is currently only indicated for prevention of chronic migraines?

A) Metoprolol

B) Botulinum toxin type A

C) Gabapentin

D) Zolmitriptan

18 / 20

Migraine Headache Treatment and Management

Question 18:

Which therapeutic class can improve outcomes when used prophylactically in MAM without aura, but are contraindicated in migraine with aura due to increased stroke risk?

A) Continuous combined hormonal contraceptives

B) Antidepressants

C) Antihypertensives

D) Long-acting triptans

19 / 20

Migraine Headache Treatment and Management

Question 19:

Anti-CGRP monoclonal antibodies, a recently-approved class of therapeutic medications, mitigate the effects of excessive CGRP released during migraine attacks, thereby reducing neuroinflammation. Which of the following is/are true supporting their effectiveness as preventative agents?

A) Self-administered agents are available as once-monthly injections, reducing the burden of daily dosing

B) Persistent exposure does not increase the risk of MOH, contrary to triptans

C) They are not associated with hepatotoxicity and evidence currently supports high tolerability

D) All of the above

20 / 20

Migraine Headache Treatment and Management

Question 20:

Which of the following is not a characteristic of Lasmiditan (Reyvow)?

A) It is a nonselective serotonin agonist

B) Reyvow can elicit CNS side effects such as temporary driving impairment

C) It is a schedule V controlled substance

D) It does not cause vasoconstriction and is a safer choice in migraine patients who have coronary risk

Your score is

Our Course Categories

Unlimited CEUs

Infection Control

Dental

Nursing

Pharmacy

Physical Therapy

Occupational Therapy

Massage Therapy

Rehab CE (🎥+PDF)

SLP & Audiology

Pharmacology CE

LCSWs/MFTs/LMHCs

Compliance

Tattoo/Body Art BBP

HIPAA Training

Biologix Solutions LLC